6550
北極星藥業-KY
-0.23 (-2.25%)9.972,215成交張數–本益比1.97股價淨值比0.00%殖利率2026-09-11資料日期
毛利率、營業利益率、淨利率
單季;近十年
單季營收
億元
| 季度 | 營收(億) | 營收年增 | 毛利(億) | 毛利率 | 營業利益(億) | 營業利益率 | 淨利率 |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 0.1 | -15.6% | -0.5 | -742.0% | -5.3 | -7429.2% | -11947.3% |
| 2026Q1 | 0.4 | 340.1% | -0.5 | -123.9% | -5.6 | -1500.0% | -1493.0% |
| 2025Q4 | 0.1 | -83.4% | -1.1 | -1899.7% | -7.3 | -12164.3% | -27944.0% |
| 2025Q3 | 0.2 | 62.3% | -0.5 | -300.6% | -7.3 | -4102.0% | -3865.0% |
| 2025Q2 | 0.1 | -73.8% | -0.6 | -746.4% | -7.3 | -8705.9% | -10630.1% |
| 2025Q1 | 0.1 | -69.6% | -0.4 | -473.3% | -6.9 | -8146.5% | -7899.7% |
| 2024Q4 | 0.4 | 639.9% | -0.3 | -93.4% | -8.5 | -2339.2% | -2328.3% |
| 2024Q3 | 0.1 | 1253.2% | -0.3 | -309.7% | -7.3 | -6689.8% | -6562.9% |
| 2024Q2 | 0.3 | 1876.8% | -0.0 | -11.3% | -5.7 | -1790.0% | -1716.9% |
| 2024Q1 | 0.3 | 18161.2% | -0.1 | -20.1% | -4.8 | -1735.2% | -1407.4% |
| 2023Q4 | 0.0 | 432.5% | -0.0 | -70.4% | -6.0 | -12197.4% | -11106.8% |
| 2023Q3 | 0.0 | 131.5% | 0.0 | 12.9% | -4.9 | -60571.7% | -52618.8% |
| 2023Q2 | 0.0 | – | 0.0 | 14.9% | -4.1 | -25419.1% | -20559.1% |
| 2023Q1 | 0.0 | – | 0.0 | 23.7% | -3.5 | -228802.6% | -180227.0% |
| 2022Q4 | 0.0 | – | 0.0 | 24.7% | -3.3 | -35470.2% | -31381.6% |
| 2022Q3 | 0.0 | – | 0.0 | 25.2% | -3.0 | -86024.1% | -87724.6% |